There is a delay to the delivery of cyclizine injection 50mg/ml and stock is now expected in Jan 2016. The company anticipates being out of stock for between 2 to 4 weeks.
“In order to preserve existing stock for critical areas, cyclizine may need to be restricted for palliative care use and no longer used as a first line antiemetic in areas where alternatives antiemetics are available, such as using ondansetron for post operative N&V. Advice should be sought from the relevant specialist team in the event of a shortage. Importers are currently investigating availability of cyclizine from outside the UK.”